Showing results (281-290 of 317) with videos related to

Sort By:
Pageof 32
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECTW Pirker, M Riedl, A Luger, et al.
Cell Reports|June 26, 2024
Neural manifolds in V1 change with top-down signals from V4 targeting the foveal regionAitor Morales-Gregorio, Anno C Kurth, Junji Ito, et al.
Der Nervenarzt|August 2, 2011
[German consortium for frontotemporal lobar degeneration]M Otto, A C Ludolph, B Landwehrmeyer, et al.
Neuropsychobiology|January 22, 2010
Homocysteine and cognitive function in geriatric depressionP Alexopoulos, S Topalidis, G Irmisch, et al.
Clinical Neuropharmacology|May 10, 2000
Clinical, pharmacokinetic, and pharmacodynamic effects of tolcapone withdrawal in levodopa-treated patients with parkinsonismK M Jorga, T L Davis, M C Kurth, et al.
Physical Review Letters|September 26, 2012
Unconventional Josephson effect in hybrid superconductor-topological insulator devicesJ R Williams, A J Bestwick, P Gallagher, et al.
Neuroepidemiology|May 21, 1998
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementiaJ P Hubble, J H Kurth, S L Glatt, et al.
Neurology|January 1, 1997
Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group IM C Kurth, C H Adler, M S Hilaire, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot studyW J Tremaine, A Brzezinski, J A Katz, et al.
Fortschritte Der Neurologie-Psychiatrie|July 8, 2009
[Sensitivity of neurochemical dementia diagnostics in CSF compared to 99mTc-SPECT in Alzheimer's dementia]M Weih, M Krinninger, R Zimmermann, et al.
Pageof 32